Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy

Background: Genetic variation near the interferon lambda 3 (IFNL3) is known to be associated with response to pegylated interferon (pegIFN) and ribavirin combination therapy in patients with chronic hepatitis C virus (HCV) infection which is often accompanied by hepatic steatosis. Aims: We examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamoto, Shingo, Imazeki, Fumio, Kanda, Tatsuo, Wu, Shuang, Nakamura, Masato, Yasui, Shin, Tawada, Akinobu, Mikata, Rintaro, Chiba, Tetsuhiro, Arai, Makoto, Yokosuka, Osamu, Shirasawa, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666539/
https://www.ncbi.nlm.nih.gov/pubmed/29104462
http://dx.doi.org/10.7150/ijms.20171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666539/
https://www.ncbi.nlm.nih.gov/pubmed/29104462
http://dx.doi.org/10.7150/ijms.20171

Ejemplares similares